patent

Uncategorized

Vedanta Aluminium Secures Patent for Breakthrough Graphite Recovery Technology on National Technology Day 2025

/

In a landmark achievement announced on National Technology Day 2025, Vedanta Aluminium, India’s largest aluminium producer, revealed that it has been granted a patent for a pioneering technology that enables the recovery of graphite with over 99% purity from aluminium production waste. This breakthrough positions the company—and the country—at the forefront of sustainable manufacturing and […]

Uncategorized

Indian Pharma Stocks Tumble Amid Trump’s Drug Price Cut Order: Industry Braces for Patent Clampdown

/

In a significant development that sent shockwaves across global pharmaceutical markets, U.S. President Donald Trump signed an executive order aimed at drastically reducing prescription drug prices in the United States. The move has triggered a sharp decline in Indian pharmaceutical stocks, raising concerns about the future of generic drug exports and the potential tightening of

Uncategorized

FEG Global Secures Patent for Innovative Emissions Scrubber, Eyes UK and European Expansion

/

An innovative engineering firm specializing in industrial equipment for the food manufacturing sector is set to expand its footprint across the UK and Europe after receiving full patent approval for its breakthrough emissions control product. FEG Global, headquartered in Washington, UK, has developed the LGC Scrubber, a patented system designed to revolutionize odour and oil

Uncategorized

“Judge Signals Sanctions Against Patent Attorney for Sharing Netflix’s Confidential Data with Litigation Funder”

/

A federal judge in Oakland has signaled his intent to impose sanctions on patent attorney Bill Ramey and his firm, Ramey LLP, for violating a protective order by sharing Netflix Inc.’s confidential information with a litigation funder. The case stems from a patent infringement lawsuit filed by Finnish inventor Lauri Valjakka against Netflix, in which

Uncategorized

Apple Patent Hints at Future Mac Devices with Gesture Control and Interactive Projection Surfaces

/

Apple Inc. has been granted a new patent that reveals ambitious plans to revolutionize how users interact with its computing devices. The patent outlines technology that could transform future MacBooks, iMacs, Magic Mouse, and Magic Keyboards by embedding a range of advanced sensors and projection systems. These innovations aim to enable gesture-based control, enhanced spatial

Uncategorized

Unilin Technologies Secures European Patent for Groundbreaking Osiris Wood Recycling Technology

/

Unilin Technologies, the intellectual property division of Unilin, has been awarded European patent EP 4114629 for its pioneering Osiris recycling technology. This patent marks a significant milestone in the company’s mission to foster circular practices in the wood industry and reflects Unilin’s ongoing investment in sustainable innovation. The patented Osiris system represents the first industrial-scale

Uncategorized

Navigating the Genomics Revolution: The Evolving Role of Intellectual Property Protection

/

More than two decades after the landmark announcement of the Human Genome Project’s completion in 2003, the field of genomics is undergoing a profound transformation. What began as a focus on decoding linear DNA sequences has expanded into a multidisciplinary understanding of the genome’s structural and functional complexity. This includes insights into protein folding, post-translational

Uncategorized

ABVC BioPharma Secures Japanese Patent for Botanical Depression Drug ABV-1504, Strengthens Global IP Portfolio

/

In a significant boost to its intellectual property portfolio, U.S.-based clinical-stage biopharmaceutical company ABVC BioPharma has received a key patent grant in Japan for its novel antidepressant candidate, ABV-1504. The newly issued patent secures exclusive rights in Japan for the innovative botanical-based treatment through 2040, reinforcing the company’s commitment to addressing global mental health challenges

drug, herbal, medicine, patent, pharma, technology

Conduit Pharmaceuticals Receives Additional Patent Approval for Lead Autoimmune Disease Asset

/

Conduit Pharmaceuticals Inc. (NASDAQ: CDT), a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases, announced today that it has received further patent approval for its lead therapeutic asset targeting autoimmune conditions. The newly granted patent strengthens the company’s intellectual property portfolio and provides added protection for its innovative approach to treating autoimmune

Scroll to Top